|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Assets | |||
| Investments, at fair value: | |||
| Non-controlled/non-affiliate company investments | |||
| Total investments, at fair value: | |||
| Cash and cash equivalents | |||
| Restricted cash and cash equivalents | |||
| Interest and dividend receivable | |||
| Deferred organizational and operating expenses | |||
| Other assets | |||
| Total assets | |||
| Liabilities | |||
| Debt | |||
| Less: Unamortized debt issuance costs | |||
| Total debt, less unamortized debt issuance costs | |||
| Interest payable | |||
| Net unrealized loss on foreign currency forward contracts | |||
| Payable for unsettled trades | |||
| Base management fees payable | |||
| Incentive fees payable | |||
| Due to Adviser | |||
| Accounts payable and accrued expenses | |||
| Distributions payable | |||
| Trustees' fees payable | |||
| Total liabilities | |||
| Net Assets | |||
| Common Shares, $0.01 par value, unlimited Common Shares authorized, 4,076,969 and 3,948,488 Class I shares issued and outstanding, respectively | |||
| Capital in excess of par value | |||
| Accumulated undistributed (overdistributed) earnings | |||
| Total net assets | |||
| Common shares outstanding (in shares) | |||
| Net asset value per share (in dollars per share) | |||
| Common stock, par value (in dollars per share) | |||
| Total liabilities and total net assets |
Loading...
